Skip to main content

Journals in Life sciences

91-100 of 941 results in All results

Biochemical Pharmacology

  • ISSN: 0006-2952
  • 5 Year impact factor: 5.8
  • Impact factor: 5.8
Biochemical Pharmacology publishes original research findings and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics. The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process. All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complementary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review. While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy. Reports describing experiments conducted with natural product mixtures, plant or animal extracts will not be considered for publication unless the structures and concentrations of all component substances are known, and the agents can be easily obtained by others wishing to replicate the study. The chemical structure of all novel compounds tested must be included in the submitted manuscript or be readily accessible in the published literature. References to structures in the patent literature must unambiguously identify a single molecular structure. All compounds, reagents, instrumentation and equipment employed in a study must be available from identified commercial suppliers, bio/pharmaceutical companies or from individuals holding legal rights to their use. Submissions will not be considered for publication if the chemical structures of tested compounds are not revealed, generally known, or accessible in the literature. Original research submissions must contain: A rationale for the selection of the compound/drug for study as well as for the concentrations/doses employed. Quantities used for concentration- and dose-response experiments should vary logarithmically, e.g., 1, 3, 10, 30 mg/kg, 0.1, 1.0, 10, 100 nanomolar, etc. Justification must be provided for studying only a single concentration or dose of a compound, especially as it relates to reference standards and antagonists/modulators of receptors, enzymes and signaling pathways. Justification must also be provided for the selection of the statistical tests employed as they relate to the experimental design. It is expected that all findings have been subjected to rigorous quantitative analyses, with the calculation and reporting of IC50, Ki, EC50, etc., values. These must be derived from a minimum of three (3) separate and distinct experiments, with the replicates within any single experiment being averaged to obtain a single value for that experimental series. Manuscripts that fail to meet these criteria will be subject to rejection without peer-review. US National Institutes of Health (NIH) voluntary posting ("Public Access") policy Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. Please bookmark this URL: https://www.elsevier.com/locate/biochempharm Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochemical Pharmacology

Biochemical Systematics and Ecology

  • ISSN: 0305-1978
  • 5 Year impact factor: 1.5
  • Impact factor: 1.6
Biochemical Systematics and Ecology is devoted to the publication of original papers and reviews, both submitted and invited, in two subject areas: I) the application of biochemistry to problems relating to systematic biology of organisms (biochemical systematics); II) the role of biochemistry in interactions between organisms or between an organism and its environment (biochemical ecology). In the Biochemical Systematics subject area, comparative studies of the distribution of (secondary) metabolites within a wider taxon (e.g. genus or family) are welcome. Comparative studies, encompassing multiple accessions of each of the taxa within their distribution are particularly encouraged. Welcome are also studies combining classical chemosystematic studies (such as comparative HPLC-MS or GC-MS investigations) with (macro-) molecular phylogenetic studies. Studies that involve the comparative use of compounds to help differentiate among species such as adulterants or substitutes that illustrate the applied use of chemosystematics are welcome. In contrast, studies solely employing macromolecular phylogenetic techniques (gene sequences, RAPD studies etc.) will be considered out of scope. Discouraged are manuscripts that report known or new compounds from a single source taxon without addressing a systematic hypothesis. Also considered out of scope are studies using outdated and hard to reproduce macromolecular techniques such as RAPDs in combination with standard chemosystematic techniques such as GC-FID and GC-MS. In the Biochemical Ecology subject area, studies addressing the role compounds play in the ecology of the organisms producing them are invited. Moreover, manuscripts that address hypothesis associated with the influence of factors such as altitude, geography, and seasonal variation on the expression of primary and secondary metabolites are encouraged. Research papers should generally represent a complete investigation and not preliminary data. Preliminary reports will only be considered where findings are of sufficient interest to justify rapid publication. New Source Reports will only be considered in cases where a significant chemosystematic or ecological finding is reported. New Source Reports have to be written in a standard format (Example).
Biochemical Systematics and Ecology

Biochemical and Biophysical Research Communications

  • ISSN: 0006-291X
  • 5 Year impact factor: 3.2
  • Impact factor: 3.1
Biochemical and Biophysical Research Communications (BBRC) is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. For short communication papers, we offer the fastest submission to acceptance of any journal within life sciences, with "accept" decisions rendered within three weeks of submission. We will now consider full-length research papers and review articles. The journal covers most of areas of life science, and is divided into the following sections: Biochemistry Biophysics Cell Biology Cellular Pathology and Cancer Computational Biology and Bioinformatics Genetics Immunology and Inflammation Microbiology and Virology Nanomedicine and Bionanomaterials Neuroscience Pharmacology Physiology Plant Biology Structural Biology Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center. Announcement: BBRC has traditionally only published short communications of novel results. From 2023, the journal now publishes short communications, full-length research papers, and reviews. What type of paper should I choose on submission? For short communications, we will still aim to make an accept or reject decision within two weeks of submission. If you have novel results that you can consolidate into 4,600 words, with no more than four figures, then you may continue to choose the short communication route. Short communications should be concise, no more than 4,600 words and up to four display items. They should offer novel insights and warrant a rapid peer review process. The 4,600 word count includes the title page, all sections of the manuscript (including the references), and the figure and table legends. Papers that exceed these limits will be reassigned within the submission system as a full-length research paper. If you submit a full-length research paper or a review paper, we will continue to offer a fast turnaround (with a decision after review within 30 days of submission), and we'll also make sure that any revisions that we request of you will not require significant resource expenditure on your part. Full-length research papers should present a comprehensive account of original research. These papers are not restricted by length or number of figures. Review papers should be authoritative, state-of-the-art accounts of the selected research field and be of high interest, balanced, and accurate. Beyond summaries of important scientific developments and ideas, authors are encouraged to identify and discuss how the field may be impacted or develop in the future, including insights that may be of significance to the scientific community. The number of co-authors of review articles is limited to five, and each author is expected to make a substantial contribution to the writing of the manuscript. There are no restrictions on length for review papers, and we welcome both comprehensive reviews and short reviews that offer an insight into more recent advances in a field.
Biochemical and Biophysical Research Communications

Biochemistry and Biophysics Reports

  • ISSN: 2405-5808
  • Impact factor: 2.7
Biochemistry and Biophysics Reports (BB Reports) publishes original research from all scientific fields in all aspects of biochemistry and biophysics and related areas, such as molecular and cell biology and environmental toxicology. BB Reports welcomes a broad range of studies, from detailed mechanistic to more preliminary, descriptive, confirmatory, and small-scale studies, as long as the studies are solid, add new data and knowledge, have the potential to contribute to future research, and confirm or refute an existing hypothesis. Primary criteria for acceptance are that the work is experimentally and methodologically correct and that it meets the ethics and standards of experimental science. We strongly believe all results deserve to be published and documented for the advancement of science. BB Reports appreciates receiving reports on • Negative results • Replication studies • Reanalysis of previous datasets BB Reports does accept methodological studies, but does not accept purely theoretical, hypothesis-generating studies without any experimental support and will not consider clinical/(genetic) epidemiological association studies. Reasons to submit your next article to BB Reports: Accessibility - Open access provides immediate and free online access to articles by anyone, anywhere in the world. No subscription needed. Quality - Our renowned international board of subject-specific Editors, guarantee a rigorous, fair and efficient peer review process. Speed - Articles are published online, quickly after acceptance. Articles are published constantly so there are no print delays or long waits for the next issue to be published. Discoverability - BB Reports is indexed in the Web of Science Emerging Sources Citation Index (not SCI), Scopus, PubMed Central (PMC) and the Directory of Open Access Journals (DOAJ). No Restrictions - Open access articles are online only so there are no restrictions on article length, and no additional page or color charges like many print/subscription journals. Similarly, as there are no printing costs, the environmental impact is lower. Readership - No subscriptions and no paywalls means more people can read and access an open access article, increasing author readership and usage. Author Impact - Creative commons licenses allow authors to retain copyright to their work while permitting others to share and reuse their research, increasing author impact and citations. Advancing Science - by providing access to vital research through open access, researchers across the world, including those in developing countries, can help make breakthrough discoveries which may benefit society and humanity. Option of co-submitting a data article to Data-in-Brief. View our Guide for Authors for more information, or contact us via: BBREP[at]elsevier.com.
Biochemistry and Biophysics Reports

Biochimica et Biophysica Acta: Bioenergetics

  • ISSN: 0005-2728
  • 5 Year impact factor: 4.1
  • Impact factor: 4.3
BBA Bioenergetics covers the area of biological membranes involved in energy transfer and conversion. In particular, it focuses on the structures obtained by X-ray crystallography and other approaches, and molecular mechanisms of the components of photosynthesis, mitochondrial and bacterial respiration, oxidative phosphorylation, motility and transport. It spans applications of structural biology, molecular modeling, spectroscopy and biophysics in these systems, through bioenergetic aspects of mitochondrial biology including biomedicine aspects of energy metabolism in mitochondrial disorders, neurodegenerative diseases like Parkinson's and Alzheimer's, aging, diabetes and even cancer. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Bioenergetics

Biochimica et Biophysica Acta: Biomembranes

  • ISSN: 0005-2736
  • 5 Year impact factor: 3.5
  • Impact factor: 3.4
BBA Biomembranes has its main focus on membrane structure, function and biomolecular organization, membrane proteins, receptors, channels and anchors, fluidity and composition, model membranes and liposomes, membrane surface studies and ligand interactions, transport studies, and membrane dynamics. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Biomembranes

Biochimica et Biophysica Acta: Gene Regulatory Mechanisms

  • ISSN: 1874-9399
  • 5 Year impact factor: 4.3
  • Impact factor: 4.7
BBA Gene Regulatory Mechanisms includes reports that describe novel insights into mechanisms of transcriptional, post-transcriptional and translational gene regulation. Special emphasis is placed on papers that identify epigenetic mechanisms of gene regulation, including chromatin, modification, and remodeling. This section also encompasses mechanistic studies of regulatory proteins and protein complexes; regulatory or mechanistic aspects of RNA processing; regulation of expression by small RNAs; genomic analysis of gene expression patterns; and modeling of gene regulatory pathways. Papers describing gene promoters, enhancers, silencers or other regulatory DNA regions must incorporate significant functions studies. The journal does not favorably review manuscripts identifying a miRNA-target pair without additional insights into the repression mechanism or significant advances in understanding regulatory pathways. In addition, the following elements should be an integral part of the study: •In silico prediction of miRNA targets must be experimentally verified using appropriate luciferase constructs and assays; •To exclude non-functional miRNA/mRNA interactions a reporter system including the whole 3'UTR of the target gene downstream the "luciferase" or GFP should be considered; •Any miRNA modulation should be validated by measuring the expression of the putative protein Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Gene Regulatory Mechanisms

Biochimica et Biophysica Acta: General Subjects

  • ISSN: 0304-4165
  • 5 Year impact factor: 3.4
  • Impact factor: 3
One of the 10 topical journals of BBA BBA General Subjects accepts for submission either original, hypothesis-driven studies or reviews covering subjects in biochemistry and biophysics that have general scientific interest for a wide audience. Interdisciplinary studies are encouraged. Descriptive studies without biochemical or biophysical mechanistic evidence and insights are discouraged. Preferred topics are: biomedicine: fundamental and emerging topics in biochemistry/biophysics with potential medical implications nanobiology/nanotechnology: nanoparticles, nanotoxicology, nanomedicine omics: genomics, proteomics, lipidomics, glycomics, bioinformatics experimentally addressing a defined biological question chemical biology: chemical compounds, drug mechanisms, synthesis of novel compounds, click chemistry structural biology: crystallography, NMR, multimeric proteins, protein dynamics, nucleic acids novel complexes: nucleic acids, pure natural compounds, synthetic compounds, protein complexes, nucleic acid derivatives cellular signaling: receptor signaling, protein phosphorylation cascades, phosphatases, secondary messengers, transcription regulation, gene expression glycobiology: sugar metabolites and metabolism, glycosylated proteins, membrane protein, glycosylation, glycomics redox biology: redox switches, glutathione and thioredoxin systems, oxygen and nitrogen radical species, superoxide, hydrogen peroxide, hydroxyl radical, nitric oxide, peroxides, hypoxia, redox regulation of transcription factors neurobiology: neuronal growth factors and nerve signaling, glial cells, autonomic and central nervous systems stem cells: differentiation, stem cell isolation and cultivation, growth factors imaging methodologies mechanistic characterization of compounds having biochemical importance and general interest (drug leads, toxicants, nutrients, metabolites). BBA General Subjects does not consider studies on the biological effects of crude extracts of natural sources unless the exact active molecules are identified, singularly characterized and evaluated.
Biochimica et Biophysica Acta: General Subjects

Biochimica et Biophysica Acta: Molecular Basis of Disease

  • ISSN: 0925-4439
  • 5 Year impact factor: 6.2
  • Impact factor: 6.2
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. Given the complex regulation of gene expression by a vast network of miRNA's, manuscripts describing the regulation of (disease-associated) genes by single miRNAs will only be considered if they provide genuine, novel insight in a disease mechanism. Further, studies restricted to a single cell line will not be considered unless they present truly novel insights. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Molecular Basis of Disease

Biochimica et Biophysica Acta: Molecular Cell Research

  • ISSN: 0167-4889
  • 5 Year impact factor: 5.3
  • Impact factor: 5.1
BBA Molecular Cell Research focuses on understanding the mechanisms of cellular processes at the molecular level. These include aspects of cellular signaling, signal transduction, cell cycle, apoptosis, intracellular trafficking, secretory and endocytic pathways, biogenesis of cell organelles, cytoskeletal structures, cellular interactions, cell/tissue differentiation and cellular enzymology. Also included are studies at the interface between Cell Biology and Biophysics which apply, for example, novel imaging methods for characterizing cellular processes. Please note: We usually do not consider descriptive manuscripts dealing with the identification of transcripts regulated by single miRNAs or lncRNAs, unless substantial new mechanistic insight into their (patho)physiological activity is provided. Descriptive evaluation of natural compounds as potential drug candidates are generally not within the purview of BBA-MCR, unless novel targets or molecular mechanisms for these compounds are identified. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Molecular Cell Research